Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high-risk multiple myeloma.
Noa BiranElli Gourna PaleoudisRena FeinmanDavid H VesoleJoshua ZenreichShuqi WangJaeil AhnMeena B BansalScott Douglas RowleyMichele L DonatoAndrew L PecoraJoshua RichterPalka AnandLaura McBrideKristin IvanovskiRobert KorngoldDavid S SiegelPublished in: American journal of hematology (2021)